United Therapeutics said the deal expands “existing complementary platform of organ manufacturing programs, which include ex-vivo lung perfusion, xenotransplantation, 3-D bioprinting, and ...

United Therapeutics aims to expand its portfolio of organ manufacturing platforms with the $91 million purchase of xenotransplant developer Miromatrix Medical. The deal shakes out to a price of $3 ...

United Therapeutics Organ Manufacturing Group Manchester, N.H. BEST PROJECT ... United Therapeutics had occupied 1.5 floors in the structure built in 1897 and, with this project, ...

United Therapeutics’ organ manufacturing efforts consist of seven investigational programs: xenoheart, xenokidney, xenothymokidney, regenerative lungs, 3D-printed lungs, 3D-printed livers, and ...

The acquisition of Miromatrix will expand United Therapeutics’ existing complementary platform of organ manufacturing programs, which include ex-vivo lung perfusion, xenotransplantation, 3-D ...

United Therapeutics announced in a company press release that it has agreed to terms to acquire Miromatrix Medical. Reportedly, the acquisition is expected to expand United Therapeutics’ existing ...

Source: United Therapeutics Corporation Fourth Quarter 2023 Financial Update. February 21, 2024. Furthermore, UTHR also has programs as part of its organ manufacturing platform in the preclinical ...

United Therapeutics Corp., a Maryland-based biotechnology company with an artificial organ manufacturing research facility in Manchester’s Millyard, says it’s no longer pursuing plans for ...

United Therapeutics in downtown Silver Spring has received FDA regulatory approval to begin clinical ... UT has gained global recognition for its groundbreaking work in organ manufacturing, ...

The acquisition of Miromatrix will expand United Therapeutics’ existing complementary platform of organ manufacturing programs, which include ex-vivo lung perfusion, xenotransplantation, 3-D ...

The acquisition of Miromatrix will expand United Therapeutics’ existing complementary platform of organ manufacturing programs, which include ex-vivo lung perfusion, xenotransplantation, 3-D ...